Lynce, F., Hernandez, A. R., Yadav, S., Buehler, R., Augdahl, G., Rahman, T., DeMeo, M., Waks, A. G., Tolaney, S. M., Tung, N. M., Garber, J. E., Tayob, N., Shapiro, G. I., Guerriero, J. (2025). AXALAP: Phase Ib study of axatilimab in combination with olaparib in
            <i>BRCA1/2</i>
            and
            <i>PALB2</i>
            -associated metastatic HER2-negative breast cancer (BC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps1143